Smith, Matthew R <br/><br/>
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.  [electronic resource] 

 -  The Journal of urology  Jun 2003 
 - 2008-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1097/01.ju.0000063820.94994.95  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--adverse effects<br/>Bone Density--drug effects<br/>Diphosphonates--therapeutic use<br/>Double-Blind Method<br/>Gonadotropin-Releasing Hormone--adverse effects<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Orchiectomy--adverse effects<br/>Osteoporosis--etiology<br/>Prostatic Neoplasms--drug therapy<br/>Zoledronic Acid